These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6369165)

  • 41. Changes in sensitivity of dopamine autoreceptors in rat striatum after subchronic treatment with methamphetamine.
    Yamada S; Yokoo H; Nishi S
    Eur J Pharmacol; 1991 Nov; 205(1):43-7. PubMed ID: 1811995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic treatment with haloperidol modifies the sensitivity of autoreceptors that modulate dopamine release in rat striatum.
    Yamada S; Yokoo H; Nishi S
    Eur J Pharmacol; 1993 Feb; 232(1):1-6. PubMed ID: 8458389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo release of [3H]gamma-aminobutyric acid in the rat neostriatum--II. Opposing effects of D1 and D2 dopamine receptor stimulation in the dorsal caudate putamen.
    Girault JA; Spampinato U; Glowinski J; Besson MJ
    Neuroscience; 1986 Dec; 19(4):1109-17. PubMed ID: 2950336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 3H-Domperidone: a selective ligand for dopamine receptors.
    Baudry M; Martres MP; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Sep; 308(3):231-7. PubMed ID: 503250
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of guanosine nucleotides of [3H]sulpiride binding to rat striatal membranes.
    Freedman SB; Poat JA; Woodruff GN
    Eur J Pharmacol; 1981 Jan; 69(1):117-8. PubMed ID: 7202509
    [No Abstract]   [Full Text] [Related]  

  • 46. Dopaminergic component of [3H]spiroperidol binding in the rat anterior cerebral cortex.
    Marchais D; Tassin JP; Bockaert J
    Brain Res; 1980 Feb; 183(1):235-40. PubMed ID: 7357406
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparison of effects of tiapride and sulpiride on D-1, D-2, D-3 and D-4 subtypes of dopamine receptors in rat striatal and bovine caudate nucleus membranes.
    Arima T; Samura N; Nomura Y; Segawa T
    Jpn J Pharmacol; 1986 Jul; 41(3):419-23. PubMed ID: 3761757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The mode of action of sulpiride as an atypical antidepressant agent.
    Jenner P; Marsden CD
    Adv Biochem Psychopharmacol; 1982; 32():85-103. PubMed ID: 7046370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain.
    Kelly E; Nahorski SR
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):508-12. PubMed ID: 2441268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of inhibitory activity of sulpiride for synaptic [3H]-spiperone binding in the rat striatum.
    Oki K; Nomura Y
    Dev Neurosci; 1982; 5(4):379-84. PubMed ID: 7140585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topographical analysis of the actions of 2(N,N-dipropyl)amino-5,6-dihydroxytetralin to cause biting behaviour and locomotor hyperactivity from the striatum of the guinea-pig.
    Costall B; De Souza CX; Naylor RJ
    Neuropharmacology; 1980 Jul; 19(7):623-31. PubMed ID: 7190654
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of dopaminergic agonists and antagonists on [3H]apomorphine binding to striatal membranes: sulpiride lack of interactions with positive cooperative [3H]apomorphine binding.
    Fujita N; Saito K; Hirata A; Iwatsubo K; Noguchi Y; Yoshida H
    Brain Res; 1980 Oct; 199(2):335-42. PubMed ID: 7417787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biochemical basis of antidepressant effect of low dose of sulpiride.
    Kaneno S; Komatsu H; Fukamauchi F; Ikawa K; Watanabe A
    Jpn J Psychiatry Neurol; 1991 Mar; 45(1):131-2. PubMed ID: 1836504
    [No Abstract]   [Full Text] [Related]  

  • 54. Motor inhibition induced by aporphine derivatives in the mouse.
    Bradbury AJ; Costall B; Naylor RJ; Neumeyer JL
    J Pharm Pharmacol; 1983 Aug; 35(8):494-9. PubMed ID: 6137533
    [No Abstract]   [Full Text] [Related]  

  • 55. Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Exp Neurol; 1991 Mar; 111(3):282-92. PubMed ID: 1825638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphorylation of membrane proteins in response to persistent stimulation of adenylate cyclase-linked dopamine receptors in slices of striatum.
    Memo M; Hanbauer I
    Neuropharmacology; 1984 Apr; 23(4):449-55. PubMed ID: 6728131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine efflux from striatum after chronic nicotine: evidence for autoreceptor desensitization.
    Harsing LG; Sershen H; Lajtha A
    J Neurochem; 1992 Jul; 59(1):48-54. PubMed ID: 1351932
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flunarizine potentiates cocaine-induced dopamine release and motor stimulation in rats.
    Pani L; Kuzmin A; Stefanini E; Gessa GL; Rossetti ZL
    Eur J Pharmacol; 1990 Nov; 190(1-2):223-7. PubMed ID: 2076754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pharmacological comparison of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99) and N-n-propyl-3-(3-hydroxyphenyl)piperidine with (3-PPP) selected dopamine agonists.
    Martin GE; Williams M; Haubrich DR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):298-304. PubMed ID: 6813451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.